» Articles » PMID: 12514650

Adherence to Practice Guidelines: the Role of Specialty Society Guidelines

Overview
Journal Am Heart J
Date 2003 Jan 7
PMID 12514650
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Physician adherence to guidelines is often poor, but the reasons have not been completely studied. We investigated whether physician adherence to guidelines for percutaneous transluminal coronary angioplasty (PTCA) and coronary artery bypass grafting (CABG) varied by source, development methods, or the extent of their evidence-base.

Methods And Results: We assessed adherence to guidelines developed by the American College of Cardiology/American Heart Association (ACC/AHA) for PTCA (1988 and 1993) and for CABG (1990) and guidelines developed by RAND for PTCA and CABG in 1990. We randomly sampled patients on Medicare who were undergoing coronary angiography in 5 states in 1991 and 1992, extracting clinical and laboratory data from medical records and using computer programs to classify the appropriateness of each procedure. A total of 543 PTCA and 676 CABG procedures were studied. By use of the 1988 ACC/AHA guidelines, 30% of PTCAs were rated class III (inappropriate), whereas 24% were class III by use of the 1993 guidelines. Only 1.5% of CABG procedures were class III with ACC/AHA guidelines. By use of RAND guidelines, 12% of PTCA and 9% of CABG procedures were classified as inappropriate.

Conclusions: Adherence to guidelines is higher when the recommendations are supported by evidence from randomized clinical trials (CABG). The credibility of the source and familiarity with the guidelines do not ensure compliance. When evidence is lacking, as with PTCA at the time of this study, guideline recommendations may lag behind appropriate changes in clinical practice. More frequent revisions coupled with on-line access have the potential to make guidelines more useful.

Citing Articles

Methods for assessing guideline adherence for invasive procedures in the care of chronic coronary artery disease: a scoping review.

Kentenich H, Muller D, Wein B, Stock S, Seleznova Y BMJ Open. 2023; 13(3):e069832.

PMID: 36921955 PMC: 10030787. DOI: 10.1136/bmjopen-2022-069832.


Evaluation of adherence to the Commission on Cancer lung cancer quality measures.

Odell D, Feinglass J, Engelhardt K, Papastefan S, Meyerson S, Bharat A J Thorac Cardiovasc Surg. 2019; 157(3):1219-1235.

PMID: 31343410 PMC: 7382915. DOI: 10.1016/j.jtcvs.2018.09.126.


Anti-IgE therapy for asthma: an audit at atertiary care centre in Saudi Arabia.

Weheba I, Abdelsayed A, Arnaout R, Zeitouni M, Mobaireek K, AlHarthi T Ann Saudi Med. 2018; 38(6):439-444.

PMID: 30531179 PMC: 6302986. DOI: 10.5144/0256-4947.2018.439.


Trends and variations in the prescribing of secondary preventative cardiovascular therapies for non-ST elevation myocardial infarction (NSTEMI) in Malaysia.

Venkatason P, Zaharan N, Ismail M, Wan Ahmad W, Zuhdi A Eur J Clin Pharmacol. 2018; 74(7):953-960.

PMID: 29582106 PMC: 5999133. DOI: 10.1007/s00228-018-2451-3.


Palliative treatment of coronary "atherosclerotic cancer" by drug-eluting or bare-metal stents: From oculo-stenotic reflex period to age of precision medicine.

Cetin E, Ozeke O, Ilkay E, Aras D, Topaloglu S, Golbasi Z Indian Heart J. 2018; 70(1):191-193.

PMID: 29455777 PMC: 5902819. DOI: 10.1016/j.ihj.2017.07.008.